Healthline: People are taking high doses of melatonin to sleep: Why experts are concerned
UC expert says taking too much melatonin could disrupt our sleep-wake cycle
According to a research letter published in the Journal of the American Medical Association, more people are taking supplemental melatonin, and at increasingly high doses. Researchers point out these findings raise safety concerns since the actual dose of melatonin supplements could be nearly 500% higher than the label indicates. In a story published by Healthline, Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine was one of the experts cited reacting to the letter.
Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine
“Melatonin is considered a dietary supplement and is not FDA approved for safety or effectiveness,” confirmed Sarah Gallucci, DO, an assistant professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine.
She added that there is an organization that confirms the claimed dosage and purity of some brands.
“Supplements that are verified by the United States Pharmacopeial convention are the most reliable,” said Gallucci. “USP verified supplements are tested to ensure that the potency and amounts match the label and that the product does not contain harmful levels of specified contaminants.”
Gallucci added that melatonin is considered “generally safe,” with few serious adverse effects.
“The most common side effects are headache, dizziness, nausea, and fatigue,” she said.
Gallucci cautioned that taking too much melatonin could disrupt our sleep-wake cycle, making it more difficult to fall asleep.
“Safe starting doses range from 2 to 5 mg,” she advised. “Melatonin does not have any addictive potential, which can be seen with some prescription sleep medications.”
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.